263 related articles for article (PubMed ID: 16292322)
1. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
Morgan MJ; Impallomeni LC; Pirona A; Rogers RD
Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
[TBL] [Abstract][Full Text] [Related]
2. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
Quednow BB; Kühn KU; Hoppe C; Westheide J; Maier W; Daum I; Wagner M
Psychopharmacology (Berl); 2007 Jan; 189(4):517-30. PubMed ID: 16425060
[TBL] [Abstract][Full Text] [Related]
3. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
Morgan MJ
Neuropsychopharmacology; 1998 Oct; 19(4):252-64. PubMed ID: 9718589
[TBL] [Abstract][Full Text] [Related]
4. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Morgan MJ; McFie L; Fleetwood H; Robinson JA
Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological function in ecstasy users: a study controlling for polydrug use.
Roiser JP; Rogers RD; Sahakian BJ
Psychopharmacology (Berl); 2007 Jan; 189(4):505-16. PubMed ID: 16163532
[TBL] [Abstract][Full Text] [Related]
6. Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.
Hanson KL; Luciana M; Sullwold K
Drug Alcohol Depend; 2008 Jul; 96(1-2):99-110. PubMed ID: 18384979
[TBL] [Abstract][Full Text] [Related]
7. Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.
Daumann J; Hensen G; Thimm B; Rezk M; Till B; Gouzoulis-Mayfrank E
Psychopharmacology (Berl); 2004 May; 173(3-4):398-404. PubMed ID: 14722704
[TBL] [Abstract][Full Text] [Related]
8. Memory deficits associated with recreational use of "ecstasy" (MDMA).
Morgan MJ
Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
[TBL] [Abstract][Full Text] [Related]
10. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
11. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
Parrott AC; Sisk E; Turner JJ
Drug Alcohol Depend; 2000 Jul; 60(1):105-10. PubMed ID: 10821995
[TBL] [Abstract][Full Text] [Related]
12. The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls.
Roiser JP; Rogers RD; Cook LJ; Sahakian BJ
Psychopharmacology (Berl); 2006 Oct; 188(2):213-27. PubMed ID: 16941121
[TBL] [Abstract][Full Text] [Related]
13. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
Roberts CA; Wetherell MA; Fisk JE; Montgomery C
Psychol Med; 2015 Jan; 45(2):395-406. PubMed ID: 25066866
[TBL] [Abstract][Full Text] [Related]
14. Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: a study comparing current and ex-ecstasy users with polydrug and drug-naive controls.
Hoshi R; Cohen L; Lemanski L; Piccini P; Bond A; Curran HV
Exp Clin Psychopharmacol; 2007 Aug; 15(4):351-8. PubMed ID: 17696682
[TBL] [Abstract][Full Text] [Related]
15. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
Gouzoulis-Mayfrank E; Daumann J; Tuchtenhagen F; Pelz S; Becker S; Kunert HJ; Fimm B; Sass H
J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694
[TBL] [Abstract][Full Text] [Related]
16. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Taurah L; Chandler C; Sanders G
Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
[TBL] [Abstract][Full Text] [Related]
17. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.
Hoshi R; Mullins K; Boundy C; Brignell C; Piccini P; Curran HV
Psychopharmacology (Berl); 2007 Oct; 194(3):371-9. PubMed ID: 17605005
[TBL] [Abstract][Full Text] [Related]
19. Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users.
Burgess AP; Venables L; Jones H; Edwards R; Parrott AC
Psychopharmacology (Berl); 2011 Aug; 216(4):545-56. PubMed ID: 21390504
[TBL] [Abstract][Full Text] [Related]
20. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
